ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing, Genet Med. juill, vol.15, issue.7, pp.565-74, 2013. ,
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations, Eur J Hum Genet, vol.26, issue.12, pp.1732-1774, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01870352
Le séquençage de nouvelle génération ( Next-Generation Sequencing , ou NGS) appliqué au diagnostic de maladies monogéniques hétérogènes: Notions essentielles pour le dialogue entre cliniciens et généticiens. Les Cahiers de Myologie, juin, issue.13, pp.31-34, 2016. ,
Clinical massively parallel sequencing for the diagnosis of myopathies, Rev Neurol (Paris). juill, vol.171, issue.6-7, pp.558-71, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01610014
Next generation sequencing technology: Advances and applications, Biochim Biophys Acta, vol.1842, issue.10, pp.1932-1973, 2014. ,
Collège national des enseignants et praticiens de génétique. Génétique médicale: enseignement thématique, 2016. ,
, Disponible sur, vol.20, pp.16-2025, 2025.
,
,
Opportunities and challenges of whole-genome and -exome sequencing, BMC Genet, vol.14, issue.1, p.14, 2017. ,
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource, Am J Hum Genet. 1 juin, vol.100, issue.6, pp.895-906, 2017. ,
,
, Hors série, vol.33, pp.30-33, 2017.
Towards an harmonization of diagnosis by NGS of neuromuscular diseases -Actions of the Molecular Genetics sub-group of FILNEMUS ,
URL : https://hal.archives-ouvertes.fr/hal-01938567
, Med Sci (Paris). nov, vol.34, pp.20-22, 2018.
A National French consensus on gene lists for the diagnosis of myopathies using nextgeneration sequencing, Eur J Hum Genet. mars, vol.27, issue.3, p.92, 2019. ,
A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation, Genet Med, vol.18, issue.12, pp.1258-68, 2016. ,
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing, Genet Med. janv, vol.17, issue.1, pp.68-77, 2015. ,
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics, Genet Med, vol.19, issue.2, pp.249-55, 2017. ,
The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG), Genet Med. 25 avr, 2019. ,
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing, Genet Med, vol.18, issue.5, pp.467-75, 2016. ,
Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group, Hum Mutat, vol.39, issue.11, pp.1677-85, 2018. ,
, Épilepsies de l'enfant et de l'adulte
Genetic diagnosis in neonatal-onset epilepsies: Back to the future, Eur J Paediatr Neurol. mai, vol.22, issue.3, pp.354-361, 2018. ,
Neonatal epilepsy genetics, Semin Fetal Neonatal Med, vol.23, issue.3, pp.197-203, 2018. ,
, Pédiatrie. Lavoisier MSP, 2009.
, ClinGen Actionability Reports
, Myopathies ou Maladies Neuromusculaire
,
, Avancées dans les Glycogénoses Musculaires, Savoir et Comprendre, Avancées de la Recherche
Biothérapies: des traitements innovants au bénéfice du plus grand nombre, 2019. ,
Disponible sur, 2019. ,
, Avancées dans Dystrophies Musculaires de Duchenne et Becker, Savoir et Comprendre, Avancées de la recherche
Disponible sur, 2019. ,
, Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application
Amyotrophie Spinale liée à SMN1, Savoir et Comprendre, Avancées de la recherche ,
Prise en charge respiratoire et maladies neuromusculaires, Savoir et Comprendre, Repères, 2019. ,
Prise en charge orthopédique et maladie neuromusculaire, Savoir et Comprendre, Repères, 2014. ,
, , 2018.
, ClinGen Pediatric Actionability Workgroup Protocol: Generation of Summary Reports and Semi-Quantitative Metric Scoring
, Banque Nationale de Données des Maladies Rares
KCNQ2-Related Disorders ,
KCNT1-Related Epilepsy, éditeurs. GeneReviews ® ,
SCN8A-Related Epilepsy with Encephalopathy ,
Neonatal epilepsies: Clinical management, Semin Fetal Neonatal Med, vol.23, issue.3, pp.204-216, 2018. ,
Outcomes of an International Workshop on Preconception Expanded Carrier Screening: Some Considerations for Governments. Front Public Health, vol.5, p.25, 2017. ,
Measuring the impact of genetic knowledge on intentions and attitudes of the community towards expanded preconception carrier screening, J Med Genet. nov, vol.55, issue.11, p.94, 2018. ,
Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners, Aust J Gen Pract, vol.48, issue.3, pp.106-116, 2019. ,
, Avancées dans les Myasthénies Congénitales, Savoir et Comprendre, Avancées de la Recherche
, éditeurs. GeneReviews ®
Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency, éditeurs. GeneReviews ® ,
,
, Financements et contrat de recherche pour l'étude du déploiement du SHD en diagnostic
,
Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests, Eur J Hum Genet. août, vol.27, issue.8, pp.1197-214, 2019. ,
Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives, Eur J Med Genet. 29 juin, 2019. ,
Comité Consultatif Nationnal d'Ethique. Données massives et santé : Etat des lieux, prospective et nouvelles questions éthiques ,
Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature, Eur J Med Genet. juin, vol.62, issue.6, p.103529, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02058797